Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 4.50 is 63% below its 5-year average of 12.17, near the low end of its 5-year range (0.00–21.15).
As of the fiscal period ended Tuesday, June 30, 2026. 31.58% below its 12-month average of 6.57.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 4.50.
QUICK RATIO (ACID-TEST)
4.50
QUICK RATIO (ACID-TEST) AVG TTM
6.57
QUICK RATIO (ACID-TEST) AVG 3Y
11.43
QUICK RATIO (ACID-TEST) AVG 5Y
12.17
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-31.58%
CURRENT VS 3Y AVG
-60.66%
CURRENT VS 5Y AVG
-63.06%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.19
median of 742 covered companies
CURRENT VS SECTOR MEDIAN
+40.93%
vs the sector median at left
Neumora Therapeutics, Inc. Common Stock
Market Cap
$90.42M
Quick Ratio (Acid-Test)
4.50
TTM Avg
6.57
3Y Avg
11.43
5Y Avg
12.17
Market Cap
$90.13M
Quick Ratio (Acid-Test)
7.70
TTM Avg
11.16
3Y Avg
14.97
5Y Avg
23.58
Market Cap
$90.73M
Quick Ratio (Acid-Test)
23.40
TTM Avg
7.13
3Y Avg
4.61
5Y Avg
6.59
Market Cap
$91.33M
Quick Ratio (Acid-Test)
1.00
TTM Avg
1.24
3Y Avg
1.67
5Y Avg
2.90
Market Cap
$89.34M
Quick Ratio (Acid-Test)
2.71
TTM Avg
1.86
3Y Avg
1.80
5Y Avg
2.82
Market Cap
$89.21M
Quick Ratio (Acid-Test)
27.26
TTM Avg
12.68
3Y Avg
13.62
5Y Avg
17.71
Market Cap
$92.20M
Quick Ratio (Acid-Test)
3.47
TTM Avg
4.19
3Y Avg
5.60
5Y Avg
16.48
Market Cap
$93.28M
Quick Ratio (Acid-Test)
1.12
TTM Avg
0.72
3Y Avg
0.57
5Y Avg
0.57
Market Cap
$86.69M
Quick Ratio (Acid-Test)
1.01
TTM Avg
1.14
3Y Avg
1.20
5Y Avg
1.25
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Neumora Therapeutics, Inc. Common Stock (NMRA) | $90.42M | 4.50 | 6.57 | 11.43 | 12.17 |
| PMV Pharmaceuticals, Inc. (PMVP)vs › | $90.13M | 7.70 | 11.16 | 14.97 | 23.58 |
| Equillium, Inc. (EQ)vs › | $90.73M | 23.40 | 7.13 | 4.61 | 6.59 |
| electroCore, Inc. (ECOR)vs › | $91.33M | 1.00 | 1.24 | 1.67 | 2.90 |
| ImmuCell Corporation (ICCC)vs › | $89.34M | 2.71 | 1.86 | 1.80 | 2.82 |
| Rallybio Corporation (RLYB)vs › | $89.21M | 27.26 | 12.68 | 13.62 | 17.71 |
| Biomea Fusion, Inc. (BMEA)vs › | $92.20M | 3.47 | 4.19 | 5.60 | 16.48 |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $93.28M | 1.12 | 0.72 | 0.57 | 0.57 |
| CareCloud, Inc. (CCLD)vs › | $86.69M | 1.01 | 1.14 | 1.20 | 1.25 |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $85.42M | 1.98 | 0.61 | 1.40 | 2.59 |
Quick Ratio
4.50
Excludes inventory
Current Ratio
4.50
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 4.50 |
| 2026-03-31 | 5.09 |
| 2025-12-31 | 5.87 |
| 2025-09-30 | 6.85 |
| 2025-06-30 | 10.54 |
| 2025-03-31 | 8.98 |
| 2024-12-31 | 10.51 |
| 2024-09-30 | 10.98 |
| 2024-06-30 | 17.22 |
| 2024-03-31 | 17.99 |
| 2023-12-31 | 19.05 |
| 2023-09-30 | 18.05 |
| 2023-06-30 | 12.90 |
| 2023-03-31 | 16.53 |
| 2022-12-31 | 16.37 |
| 2022-09-30 | 0.00 |
| 2022-06-30 | 14.89 |
| 2022-03-31 | 20.24 |
| 2021-12-31 | 17.85 |
| 2021-09-30 | 21.15 |
| 2021-06-30 | 0.00 |
| 2021-03-31 | 0.00 |
| 2020-12-31 | 20.69 |
